# Crown Holdings, Inc.: financial statements, quarterly

CCK · NYSE · CIK 1219601 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/cck.md) · [Financials](/companies/cck/financials.md) · [Filings](/companies/cck/filings.md) · [Insiders](/companies/cck/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/cck/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [2,858 d](/filings/0001628280-26-012904.md) | [2,784](/filings/0001219601-25-000015.md) | [3,040](/filings/0001219601-25-000036.md) | [3,074](/filings/0001628280-25-047477.md) | [2,903 d](/filings/0001628280-26-012904.md) | [2,887](/filings/0001628280-26-029288.md) | [3,149](/filings/0001628280-26-050949.md) | [3,202](/filings/0001628280-26-067841.md) | [3,127 d](/filings/0001628280-26-012904.md) | [3,259](/filings/0001628280-26-029288.md) | [3,668](/filings/0001628280-26-050949.md) | [3,711](/filings/0001628280-26-067841.md) |
| Gross profit | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Selling, general and administrative | $m | [145 d](/filings/0001628280-26-012904.md) | [154](/filings/0001219601-25-000015.md) | [150](/filings/0001219601-25-000036.md) | [146](/filings/0001628280-25-047477.md) | [147 d](/filings/0001628280-26-012904.md) | [152](/filings/0001628280-26-029288.md) | [161](/filings/0001628280-26-050949.md) | [155](/filings/0001628280-26-067841.md) | [164 d](/filings/0001628280-26-012904.md) | [159](/filings/0001628280-26-029288.md) | [166](/filings/0001628280-26-050949.md) | [159](/filings/0001628280-26-067841.md) |
| Operating income | $m | [259 d](/filings/0001628280-26-012904.md) | [245](/filings/0001219601-25-000015.md) | [379](/filings/0001219601-25-000036.md) | [444](/filings/0001628280-25-047477.md) | [351 d](/filings/0001628280-26-012904.md) | [365](/filings/0001628280-26-029288.md) | [391](/filings/0001628280-26-050949.md) | [423](/filings/0001628280-26-067841.md) | [374 d](/filings/0001628280-26-012904.md) | [365](/filings/0001628280-26-029288.md) | [464](/filings/0001628280-26-050949.md) | [442](/filings/0001628280-26-067841.md) |
| Interest expense | $m | [113 d](/filings/0001219601-25-000009.md) | [113](/filings/0001219601-24-000015.md) | [112](/filings/0001219601-25-000036.md) | [119](/filings/0001628280-25-047477.md) | [108 d](/filings/0001219601-25-000009.md) | [99.0](/filings/0001628280-26-029288.md) | [103](/filings/0001628280-26-050949.md) | [101](/filings/0001628280-26-067841.md) | [95.0 d](/filings/0001628280-26-012904.md) | [97.0](/filings/0001628280-26-029288.md) | [105](/filings/0001628280-26-050949.md) | [97.0](/filings/0001628280-26-067841.md) |
| Income tax | $m | [59.0 d](/filings/0001628280-26-012904.md) | [40.0](/filings/0001219601-25-000015.md) | [54.0](/filings/0001219601-25-000036.md) | [(39.0)](/filings/0001628280-25-047477.md) | [128 d](/filings/0001628280-26-012904.md) | [46.0](/filings/0001628280-26-029288.md) | [78.0](/filings/0001628280-26-050949.md) | [84.0](/filings/0001628280-26-067841.md) | [73.0 d](/filings/0001628280-26-012904.md) | [70.0](/filings/0001628280-26-029288.md) | [89.0](/filings/0001628280-26-050949.md) | [89.0](/filings/0001628280-26-067841.md) |
| Net income | $m | [32.0 d](/filings/0001628280-26-012904.md) | [67.0](/filings/0001219601-25-000015.md) | [174](/filings/0001219601-25-000036.md) | [(175)](/filings/0001628280-25-047477.md) | [358 d](/filings/0001628280-26-012904.md) | [193](/filings/0001628280-26-029288.md) | [181](/filings/0001628280-26-050949.md) | [214](/filings/0001628280-26-067841.md) | [150 d](/filings/0001628280-26-012904.md) | [175](/filings/0001628280-26-029288.md) | [245](/filings/0001628280-26-050949.md) | [225](/filings/0001628280-26-067841.md) |
| Diluted EPS | $ per share | not reported | [0.56](/filings/0001219601-25-000015.md) | [1.45](/filings/0001219601-25-000036.md) | [(1.47)](/filings/0001628280-25-047477.md) | not reported | [1.65](/filings/0001628280-26-029288.md) | [1.56](/filings/0001628280-26-050949.md) | [1.85](/filings/0001628280-26-067841.md) | not reported | [1.56](/filings/0001628280-26-029288.md) | [2.23](/filings/0001628280-26-050949.md) | [2.08](/filings/0001628280-26-067841.md) |
| Basic EPS | $ per share | not reported | [0.56](/filings/0001219601-25-000015.md) | [1.45](/filings/0001219601-25-000036.md) | [(1.47)](/filings/0001628280-25-047477.md) | not reported | [1.65](/filings/0001628280-26-029288.md) | [1.57](/filings/0001628280-26-050949.md) | [1.86](/filings/0001628280-26-067841.md) | not reported | [1.56](/filings/0001628280-26-029288.md) | [2.24](/filings/0001628280-26-050949.md) | [2.09](/filings/0001628280-26-067841.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Gross profit: not reported
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [1.3](/filings/0001219601-25-000009.md) | [1.1](/filings/0001219601-24-000015.md) | [1.4](/filings/0001219601-24-000029.md) | [1.7](/filings/0001219601-24-000038.md) | [0.9](/filings/0001628280-26-012904.md) | [0.8](/filings/0001219601-25-000015.md) | [0.9](/filings/0001219601-25-000036.md) | [1.2](/filings/0001628280-25-047477.md) | [0.8](/filings/0001628280-26-067841.md) | [0.6](/filings/0001628280-26-029288.md) | [0.7](/filings/0001628280-26-050949.md) | [0.6](/filings/0001628280-26-067841.md) |
| Current assets | $bn | [4.8](/filings/0001219601-25-000009.md) | [4.6](/filings/0001219601-24-000015.md) | [4.9](/filings/0001219601-24-000029.md) | [5.1](/filings/0001219601-24-000038.md) | [4.2](/filings/0001628280-26-012904.md) | [4.2](/filings/0001219601-25-000015.md) | [4.7](/filings/0001219601-25-000036.md) | [4.8](/filings/0001628280-25-047477.md) | [4.4](/filings/0001628280-26-067841.md) | [4.5](/filings/0001628280-26-029288.md) | [4.8](/filings/0001628280-26-050949.md) | [4.9](/filings/0001628280-26-067841.md) |
| Total assets | $bn | [15.0](/filings/0001219601-25-000009.md) | [14.7](/filings/0001219601-24-000015.md) | [14.9](/filings/0001219601-24-000029.md) | [15.1](/filings/0001219601-24-000038.md) | [13.8](/filings/0001628280-26-012904.md) | [13.8](/filings/0001219601-25-000015.md) | [14.5](/filings/0001219601-25-000036.md) | [14.6](/filings/0001628280-25-047477.md) | [14.3](/filings/0001628280-26-067841.md) | [14.3](/filings/0001628280-26-029288.md) | [14.6](/filings/0001628280-26-050949.md) | [14.6](/filings/0001628280-26-067841.md) |
| Current liabilities | $bn | [4.2](/filings/0001219601-25-000009.md) | [3.9](/filings/0001219601-24-000015.md) | [4.7](/filings/0001219601-24-000029.md) | [4.2](/filings/0001219601-24-000038.md) | [3.5](/filings/0001628280-26-012904.md) | [4.8](/filings/0001219601-25-000015.md) | [4.4](/filings/0001219601-25-000036.md) | [4.1](/filings/0001628280-25-047477.md) | [4.3](/filings/0001628280-26-067841.md) | [4.1](/filings/0001628280-26-029288.md) | [4.6](/filings/0001628280-26-050949.md) | [4.3](/filings/0001628280-26-067841.md) |
| Long-term debt | $bn | [6.7](/filings/0001219601-25-000009.md) | [6.6](/filings/0001219601-24-000015.md) | [5.9](/filings/0001219601-24-000029.md) | [6.7](/filings/0001219601-24-000038.md) | [6.1](/filings/0001628280-26-012904.md) | [4.7](/filings/0001219601-25-000015.md) | [5.6](/filings/0001219601-25-000036.md) | [5.8](/filings/0001628280-25-047477.md) | [5.4](/filings/0001628280-26-067841.md) | [5.7](/filings/0001628280-26-029288.md) | [5.5](/filings/0001628280-26-050949.md) | [5.7](/filings/0001628280-26-067841.md) |
| Current portion of debt | $bn | [0.8](/filings/0001219601-25-000009.md) | [0.7](/filings/0001219601-24-000015.md) | [1.4](/filings/0001219601-24-000029.md) | [0.7](/filings/0001219601-24-000038.md) | [0.1](/filings/0001628280-26-012904.md) | [1.5](/filings/0001219601-25-000015.md) | [0.7](/filings/0001219601-25-000036.md) | [0.5](/filings/0001628280-25-047477.md) | [0.5](/filings/0001628280-26-067841.md) | [0.5](/filings/0001628280-26-029288.md) | [0.5](/filings/0001628280-26-050949.md) | [0.1](/filings/0001628280-26-067841.md) |
| Short-term borrowings | $bn | [0.0](/filings/0001219601-25-000009.md) | [0.1](/filings/0001219601-24-000015.md) | [0.1](/filings/0001219601-24-000029.md) | [0.1](/filings/0001219601-24-000038.md) | [0.1](/filings/0001628280-26-012904.md) | [0.2](/filings/0001219601-25-000015.md) | [0.2](/filings/0001219601-25-000036.md) | [0.1](/filings/0001628280-25-047477.md) | [0.1](/filings/0001628280-26-067841.md) | [0.1](/filings/0001628280-26-029288.md) | [0.0](/filings/0001628280-26-050949.md) | [0.0](/filings/0001628280-26-067841.md) |
| Shareholders' equity | $bn | [2.4](/filings/0001219601-25-000009.md) | [2.5](/filings/0001219601-24-000015.md) | [2.5](/filings/0001219601-24-000029.md) | [2.5](/filings/0001219601-24-000038.md) | [2.8](/filings/0001628280-26-012904.md) | [2.7](/filings/0001219601-25-000015.md) | [2.9](/filings/0001219601-25-000036.md) | [3.0](/filings/0001628280-25-047477.md) | [3.0](/filings/0001628280-26-067841.md) | [2.9](/filings/0001628280-26-029288.md) | [2.9](/filings/0001628280-26-050949.md) | [2.9](/filings/0001628280-26-067841.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [621 d](/filings/0001628280-26-012904.md) | [(102)](/filings/0001219601-25-000015.md) | [445 d](/filings/0001219601-25-000036.md) | [554 d](/filings/0001628280-25-047477.md) | [295 d](/filings/0001628280-26-012904.md) | [14.0](/filings/0001628280-26-029288.md) | [449 d](/filings/0001628280-26-050949.md) | [580 d](/filings/0001628280-26-067841.md) | [487 d](/filings/0001628280-26-012904.md) | [(54.0)](/filings/0001628280-26-029288.md) | [713 d](/filings/0001628280-26-050949.md) | [406 d](/filings/0001628280-26-067841.md) |
| Capital expenditure | $m | [179 d](/filings/0001628280-26-012904.md) | [94.0](/filings/0001219601-25-000015.md) | [84.0 d](/filings/0001219601-25-000036.md) | [76.0 d](/filings/0001628280-25-047477.md) | [149 d](/filings/0001628280-26-012904.md) | [33.0](/filings/0001628280-26-029288.md) | [56.0 d](/filings/0001628280-26-050949.md) | [92.0 d](/filings/0001628280-26-067841.md) | [232 d](/filings/0001628280-26-012904.md) | [87.0](/filings/0001628280-26-029288.md) | [116 d](/filings/0001628280-26-050949.md) | [107 d](/filings/0001628280-26-067841.md) |
| Dividends paid | $m | [29.0 d](/filings/0001628280-26-012904.md) | [30.0](/filings/0001219601-25-000015.md) | [30.0 d](/filings/0001219601-25-000036.md) | [30.0 d](/filings/0001628280-25-047477.md) | [29.0 d](/filings/0001628280-26-012904.md) | [30.0](/filings/0001628280-26-029288.md) | [30.0 d](/filings/0001628280-26-050949.md) | [30.0 d](/filings/0001628280-26-067841.md) | [30.0 d](/filings/0001628280-26-012904.md) | [39.0](/filings/0001628280-26-029288.md) | [38.0 d](/filings/0001628280-26-050949.md) | [38.0 d](/filings/0001628280-26-067841.md) |
| Share repurchases | $m | [0.0 d](/filings/0001628280-26-012904.md) | [5.0](/filings/0001219601-25-000015.md) | [2.0 d](/filings/0001219601-25-000036.md) | [110 d](/filings/0001628280-25-047477.md) | [100 d](/filings/0001628280-26-012904.md) | [203](/filings/0001628280-26-029288.md) | [6.0 d](/filings/0001628280-26-050949.md) | [105 d](/filings/0001628280-26-067841.md) | [191 d](/filings/0001628280-26-012904.md) | [212](/filings/0001628280-26-029288.md) | [305 d](/filings/0001628280-26-050949.md) | [81.0 d](/filings/0001628280-26-067841.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [120](/filings/0001219601-24-000015.md) | [120](/filings/0001219601-24-000029.md) | [120](/filings/0001219601-24-000038.md) | [120](/filings/0001219601-25-000015.md) | [120](/filings/0001219601-25-000036.md) | [119](/filings/0001628280-25-047477.md) | [117](/filings/0001628280-26-029288.md) | [116](/filings/0001628280-26-050949.md) | [116](/filings/0001628280-26-067841.md) | [113](/filings/0001628280-26-029288.md) | [110](/filings/0001628280-26-050949.md) | [108](/filings/0001628280-26-067841.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 108,051,473 at 2026-10-26, from the cover of the [10-Q filed 2026-10-28](/filings/0001628280-26-067841.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 29, 2026, 19:06 ET. No prices; not investment advice.